Home2019-03-27T07:27:50-07:00

Are Thrombolytics Safe for Acute Ischemic Strokes in Patients on DOACs?

Background Direct-acting oral anticoagulants (DOACs), including apixaban, rivaroxaban, edoxaban, and [+]

Shuhan He, MD
ALiEM Senior Systems Engineer;
Director of Growth, Strategic Alliance Initiative, Center for Innovation and Digital Health
Massachusetts General Hospital;
Chief Scientific Officer, Conductscience.com
Shuhan He, MD
Go to Top